Skip to main content
Home

Leading research for life changing results

  • Our Role & Impact
    • About HMRI
    • Our Team
    • Research Funded through HMRI
    • Our Foundations
      • HMRI Foundation
      • HMRI Sydney Foundation
      • HCRF
      • HTRF
      • Borne HMRI
    • Awards and Recognition
      • Researcher Awards
      • HMRI Exceptional Service
    • Our Partnerships
    • Governance
    • Careers
    • Contact Us
  • Medical Research
    • Research
    • Researchers
    • Participate In Research
    • Coronavirus (COVID-19)
  • Support HMRI
    • Donate Online
    • Your Impact
    • Ways to Donate
    • Fundraise
    • Bequests
    • Volunteer
    • Company Donors
  • For Researchers
    • HMRI Connect Researcher Intranet
    • Services for Researchers
      • Clinical Trials Unit
      • Bioinformatics & Special Applications Support
      • Clinical Research Design and Statistics
      • Health Research Economists
      • Funding Support
      • Research Study Recruitment
      • Clinical Trials Roadmap
    • Facilities and Equipment for Researchers
    • Register to be a HMRI Researcher
  • Events
    • Upcoming Events
  • News & Articles
  1. Home
  2. Search Results

Search Results

  • All (10) Remove All (10) filter
  • News & Articles (6)
  • Research (3)
  • Researcher Profiles (1)

Search found 10 items

All
Grant boost for study into acute myeloid leukaemia target
Category: News & Articles
... week, with a project aimed at developing a new targeted treatment for acute myeloid leukaemia. HMRI researcher Dr Kathryn Skelding is one of 17 young ... is also collaborating with colleague Dr Nikki Verrills on an acute lymphoblastic leukaemia project, studying a new mechanism for ...
Leukaemia
Category: Research
Leukaemia is a cancer of the blood or bone marrow involving abnormal ... every year. (Source – Australian Institute of Health and Welfare ) Acute Lymphoblastic Leukaemia (ALL) is one of the most deadly and most common ...
Strengthening the defence against leukaemia
Category: News & Articles
... Dr Matt Dun has revealed a more targeted way of treating T-cell acute lymphoblastic leukaemia (T-ALL), an aggressive cancer prevalent in children. Research ...
Identification of novel markers in paediatric acute lymphoblastic leukaemia; investigation of DNA methylations and non-coding small microRNAs
Category: Research
Research Identification of novel markers in paediatric acute lymphoblastic leukaemia; investigation of DNA methylations and non-coding small ...
SKI 4 KIDS to aid Leukaemia Research
Category: News & Articles
... conducted by HMRI into the most common type of childhood cancer, Acute Lymphoblastic Leukaemia (A.L.L). Geary, proprietor of the Good Guys Kotara, his ...
Nikki Verrills
Category: Researcher Profiles
... but do not affect normal healthy cells. My work is applicable to all cancer types, but I focus primarily on two diseases: Acute myeloid leukaemia (AML) – the most common adult leukaemia, with a dismal 5year ...
Re-purposing PARP inhibitors to treat childhood leukaemias
Category: Research
... is the most common cause of childhood disease-related deaths, with leukaemia the most common childhood cancer in Australia. The two most common forms of leukaemia in children are acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML). Whilst ...
HMRI Awards Night 2018 Winners
Category: News & Articles
... Awarded to Dr Andrew Ziolkowski | An A(r)Ray of hope for paediatric Acute Lymphoblastic Leukaema – improving risk stratification and outcome. ... on kidney function for infants in the Gomeroi gaaynggal cohort. HMRI Leukaemia Project Grant Awarded to Dr Danielle Bond | How does the bone ...
HMRI 2010/2011 Project Grant Recipients
Category: News & Articles
... and cellular aging. This study will test this hypothesis of both acute and chronic stress to provide an explanation of stress-induced ... PP2A as a Novel Therapeutic Strategy for mutant FLT3+ Acute Myeloid Leukaemia Recent advancements in medical research have led to remarkable ... of PP2A activating compounds for the treatment of childhood acute lymphoblastic leukaemia This project will show for the first time, the ...
Record total for HCRF awards
Category: News & Articles
... as biomarker and unique target for anti-cancer therapy in paediatric acute lymphoblastic leukaemia             Researchers have identified a unique marker ...
  • Contact us
  • View Research & Diseases
  • News & Articles
  • Site Map
  • Privacy Policy
  • ​
  • HUNTER MEDICAL RESEARCH INSTITUTE ABN 27 081 436 919 | Phone (02) 4042 0000 |  Donation Hotline 1300 993 822
  •  
  • Copyright © Hunter Medical Research Institute 2022
  •  
  • Tata Consultancy Services